GADSDEN REPORT
Don't Tread On The Truth
Culture & Tech

FDA Approves Pancreatic Cancer Drug That Nearly Doubled Survival In Trial

The U.S. Food and Drug Administration (FDA) on Wednesday approved a groundbreaking new treatment for advanced pancreatic cancer that nearly doubled median survival in a clinical trial, marking what experts are calling one of the biggest advances against the deadly disease in decades. Read more at DAILY WIRE ›
Read the full story at
DAILY WIRE
Open the original

The Gadsden Report aggregates and summarises headlines. The reporting above belongs to DAILY WIRE, and the link opens their page. This page exists so readers can find, share, and discuss the story here.

Discussion — 0 comments

No comments yet. Be the first.